United Kingdom· GB-APID-3691211000001101
Tarka modified-release capsules
A trandolapril and verapamil product containing verapamil + trandolapril, registered in United Kingdom by Abbott Laboratories Ltd. The same ATC class is registered in 6 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Trandolapril and verapamil is registered in 6 of 19 countries.
Countries holding a registration under ATC C09BB10 (trandolapril and verapamil), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Trandolapril and verapamil · ATC C09BB10
6 / 19 countries
- Czechiaprice
- Finlandprice
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Verapamil + Trandolapril
- Manufacturer
- Abbott Laboratories Ltd
- Country
- United Kingdom (GB)
- ATC code
- C09BB10
- ATC class
- Trandolapril and verapamil
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5016565111445
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
71 interactions on record for trandolapril and verapamil.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trandolapril and verapamil · interactions on record
71 records
71 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Trandolapril and verapamil in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTARKAVIATRIS HEALTHCARE LIMITED, Dublin
- NetherlandsTarka 180 mg/2 mg, capsules met gereguleerde afgifteViatris Healthcare Limited
- United StatesTrandolapril and Verapamil HydrochlorideGlenmark Pharmaceuticals Inc., USA
- FinlandTarkaAbbott Scandinavia AB
- FranceTARKA LP 180 mg/2 mg, comprimé pelliculé à libération prolongéeVIATRIS MEDICAL
- SwitzerlandTarka, FilmtablettenViatris Pharma GmbH
- GermanyTarkaViatris Healthcare Gmbh
- SpainTARKA 180 mg/ 2 mg CAPSULAS DE LIBERACION MODIFICADAViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Bulgaria · Таркa, Тарка
- Czechia · Tarka
- Germany · Tarka
- Estonia · Tarka
- Spain · Tarka
- France · Tarka Lp
- Croatia · Tarka
- Hungary · Tarka
- Lithuania · Tarka
- Luxembourg · Tarka
- Latvia · Tarka
- Netherlands · Tarka
- Romania · Tarka
- Slovenia · Tarka
- Slovakia · Tarka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/18d41c0f-3e8d-4388-896e-a66cf93fd2ab GET /v1/drugs/18d41c0f-3e8d-4388-896e-a66cf93fd2ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3691211000001101",
"desc": "Tarka modified-release capsules (Abbott Laboratories Ltd)",
"form": "Modified-release capsule",
"vpid": "36149211000001102",
"source": "dmd",
"vtm_id": "777820000",
"strength": "180 mg",
"substance": "Verapamil + Trandolapril",
"ingredient": "Verapamil hydrochloride",
"supplier_code": "2061801000001104"
}See everything about trandolapril and verapamil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.